Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Clin Cancer Res
.
2021 Jan 1;27(1):357.
doi: 10.1158/1078-0432.CCR-20-4484.
Authors
Ravindra Uppaluri
,
Katie M Campbell
,
Ann Marie Egloff
,
Paul Zolkind
,
Zachary L Skidmore
,
Brian Nussenbaum
,
Randal C Paniello
,
Jason T Rich
,
Ryan Jackson
,
Patrik Pipkorn
,
Loren S Michel
,
Jessica Ley
,
Peter Oppelt
,
Gavin P Dunn
,
Erica K Barnell
,
Nicholas C Spies
,
Tianxiang Lin
,
Tiantian Li
,
David T Mulder
,
Youstina Hanna
,
Iulia Cirlan
,
Trevor J Pugh
,
Tenny Mudianto
,
Rachel Riley
,
Liye Zhou
,
Vickie Y Jo
,
Matthew D Stachler
,
Glenn J Hanna
,
Jason Kass
,
Robert Haddad
,
Jonathan D Schoenfeld
,
Evisa Gjini
,
Ana Lako
,
Wade Thorstad
,
Hiram A Gay
,
Mackenzie Daly
,
Scott J Rodig
,
Ian S Hagemann
,
Dorina Kallogjeri
,
Jay F Piccirillo
,
Rebecca D Chernock
,
Malachi Griffith
,
Obi L Griffith
,
Douglas R Adkins
PMID:
33397681
DOI:
10.1158/1078-0432.CCR-20-4484
No abstract available
Publication types
Published Erratum